Piperine treatment can down-regulate the TGF-ß/SMAD signaling pathway along with this piperine can also inhibit the expression of fibronectin-1, collagen I/III and α-SMA. Inhibition of all of these pathways leads to inhibition of the cancer potential of PSC. The gene discussed is ACTA1; the disease is cancer.